Evidence map›Paper›PMID 40129791›Full record

ArticleRadiology case reports2025

Late-onset bone granulomatous reaction of hand from immune checkpoint-inhibitors detected on FDG-PET/CT.

Miki Nishimori, Kouki Togami, Noriko Nitta, Kana Miyatake, Hitomi Iwasa, Kosuke Nakaji, Kenta Ogi, Takayasu Izumi, Tomohiro Matsumoto, Rika Yoshimatsu and 5 more

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Miki NishimoriDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Kouki TogamiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Noriko NittaDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Kana MiyatakeDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Hitomi IwasaDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Kosuke NakajiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Kenta OgiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Takayasu IzumiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Tomohiro MatsumotoDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Rika YoshimatsuDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Tomoaki YamanishiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Kazufumi TakamatsuDepartment of Respiratory medicine and Allergology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Shudai MuramatsuDepartment of Orthopedic Surgery, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Mayuko YamamotoDepartment of Dermatology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Takuji YamagamiDepartment of Diagnostic and Interventional Radiology, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitors (ICIs) enhance antitumor immunity by inhibiting intrinsic immune-suppressive pathways. Although immune-related adverse events (irAEs) typically arise in the early phase of ICI therapy, delayed manifestations have been reported, even months to years following treatment discontinuation. We report a case of a late-onset bone granulomatous reaction in the hand of a male patient in his seventies with a history of ICI therapy, identified on FDG-PET/CT, 4 years after discontinuation of ICI therapy. This case indicates the importance of recognizing the possibility of delayed irAEs, even in patients who have undergone long-term discontinuation of immunotherapy.

Indexed as

Bone granulomatous reactionFDG-PET/CTImmune-related adverse event (irAE)Late-onsetPembrolizumab

Identifiers

PMID40129791
PMCPMC11930533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.